PL2774910T3 - Enancjomery 2-hydroksy pochodnych kwasów tłuszczowych - Google Patents
Enancjomery 2-hydroksy pochodnych kwasów tłuszczowychInfo
- Publication number
- PL2774910T3 PL2774910T3 PL12838506T PL12838506T PL2774910T3 PL 2774910 T3 PL2774910 T3 PL 2774910T3 PL 12838506 T PL12838506 T PL 12838506T PL 12838506 T PL12838506 T PL 12838506T PL 2774910 T3 PL2774910 T3 PL 2774910T3
- Authority
- PL
- Poland
- Prior art keywords
- enantiomers
- fatty acids
- hydroxy derivatives
- hydroxy
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
- C07C51/487—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
- C07C51/493—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification whereby carboxylic acid esters are formed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201131622A ES2401629B1 (es) | 2011-10-07 | 2011-10-07 | Enantiómeros de 2-hidroxiderivados de ácidos grasos y su uso como medicamentos. |
| US201261610762P | 2012-03-14 | 2012-03-14 | |
| EP12838506.9A EP2774910B1 (en) | 2011-10-07 | 2012-10-08 | Enantiomers of 2-hydroxy derivatives of fatty acids |
| PCT/ES2012/070697 WO2013050644A1 (es) | 2011-10-07 | 2012-10-08 | Enantiómeros de 2-hidroxiderivados de ácidos grasos |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2774910T3 true PL2774910T3 (pl) | 2018-03-30 |
Family
ID=48043212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12838506T PL2774910T3 (pl) | 2011-10-07 | 2012-10-08 | Enancjomery 2-hydroksy pochodnych kwasów tłuszczowych |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9359281B2 (pl) |
| EP (2) | EP3287437B1 (pl) |
| JP (1) | JP2014530806A (pl) |
| CN (1) | CN104321300A (pl) |
| DK (1) | DK2774910T3 (pl) |
| ES (3) | ES2401629B1 (pl) |
| HU (1) | HUE035430T2 (pl) |
| IN (1) | IN2014CN03111A (pl) |
| PL (1) | PL2774910T3 (pl) |
| PT (1) | PT2774910T (pl) |
| RU (2) | RU2637937C2 (pl) |
| WO (1) | WO2013050644A1 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2345241B1 (es) * | 2009-03-16 | 2011-09-08 | Lipopharma Therapeutics | Uso de 2-hidroxiderivados de acidos grasos poliinsaturados como medicamentos. |
| ES2731251T3 (es) * | 2014-10-21 | 2019-11-14 | Univ Illes Balears | Compuestos de 2-hidroxi-triacilglicerol para uso en el tratamiento de una enfermedad |
| US11260042B2 (en) * | 2017-05-16 | 2022-03-01 | Ability Pharmaceuticals S.L. | Pharmaceutical combination for the treatment of cancer |
| WO2019099664A1 (en) * | 2017-11-16 | 2019-05-23 | The Research Foundation For The State University Of New York | Use of 2-hydroxyoleic acid for the treatment of systemic lupus erythematosus and other immune pathologies |
| BR112022015172A2 (pt) * | 2020-01-29 | 2022-10-11 | Univ Illes Balears | Metabólitos de ácidos graxos alfa-hidroxilados, usos médicos dos mesmos e uso como biomarcadores |
| ES2846824B2 (es) * | 2020-01-29 | 2022-01-19 | Univ Illes Balears | Profarmacos de acidos grasos poliinsaturados y usos medicos de los mismos |
| ES2911474B2 (es) * | 2020-11-17 | 2023-02-06 | Univ Illes Balears | Profarmacos de acidos grasos monoinsaturados y sus metabolitos: usos medicos y como biomarcadores |
| AU2021220258A1 (en) * | 2020-02-10 | 2022-06-30 | Ability Pharmaceuticals S.L. | A pharmaceutical combination for the treatment of a cancer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2235541C2 (ru) * | 1994-10-04 | 2004-09-10 | Эмори Юниверсити | Лечение атеросклероза и других сердечно-сосудистых и воспалительных заболеваний |
| AUPR547601A0 (en) * | 2001-06-05 | 2001-06-28 | Carcraft Qld Pty Ltd | Tab with writing surface |
| ES2186576B1 (es) * | 2001-10-11 | 2004-09-16 | Universitat De Les Illes Balears | Acido 2-hidroxioleico para utilizar como medicamento. |
| ES2342997B1 (es) * | 2008-12-09 | 2011-06-06 | Universitat De Les Illes Balears | Alpha derivados de acidos grasos cis-monoinsaturados para ser usados como medicamento. |
| ES2345241B1 (es) * | 2009-03-16 | 2011-09-08 | Lipopharma Therapeutics | Uso de 2-hidroxiderivados de acidos grasos poliinsaturados como medicamentos. |
-
2011
- 2011-10-07 ES ES201131622A patent/ES2401629B1/es active Active
-
2012
- 2012-10-08 ES ES12838506.9T patent/ES2653675T3/es active Active
- 2012-10-08 RU RU2014118123A patent/RU2637937C2/ru not_active Application Discontinuation
- 2012-10-08 EP EP17191078.9A patent/EP3287437B1/en active Active
- 2012-10-08 JP JP2014533953A patent/JP2014530806A/ja active Pending
- 2012-10-08 HU HUE12838506A patent/HUE035430T2/en unknown
- 2012-10-08 PL PL12838506T patent/PL2774910T3/pl unknown
- 2012-10-08 EP EP12838506.9A patent/EP2774910B1/en active Active
- 2012-10-08 CN CN201280060748.XA patent/CN104321300A/zh active Pending
- 2012-10-08 WO PCT/ES2012/070697 patent/WO2013050644A1/es active Application Filing
- 2012-10-08 IN IN3111CHN2014 patent/IN2014CN03111A/en unknown
- 2012-10-08 US US14/349,962 patent/US9359281B2/en active Active
- 2012-10-08 RU RU2017141446A patent/RU2687967C2/ru active
- 2012-10-08 DK DK12838506.9T patent/DK2774910T3/en active
- 2012-10-08 ES ES17191078T patent/ES2773784T3/es active Active
- 2012-10-08 PT PT128385069T patent/PT2774910T/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT2774910T (pt) | 2018-01-03 |
| IN2014CN03111A (pl) | 2015-07-03 |
| EP2774910A4 (en) | 2015-02-25 |
| CN104321300A (zh) | 2015-01-28 |
| EP2774910B1 (en) | 2017-09-27 |
| US9359281B2 (en) | 2016-06-07 |
| DK2774910T3 (en) | 2018-01-08 |
| ES2773784T3 (es) | 2020-07-14 |
| RU2017141446A3 (pl) | 2019-02-13 |
| RU2637937C2 (ru) | 2017-12-08 |
| RU2687967C2 (ru) | 2019-05-17 |
| JP2014530806A (ja) | 2014-11-20 |
| EP3287437A1 (en) | 2018-02-28 |
| ES2401629A1 (es) | 2013-04-23 |
| ES2653675T3 (es) | 2018-02-08 |
| US20140288176A1 (en) | 2014-09-25 |
| RU2017141446A (ru) | 2019-02-13 |
| WO2013050644A1 (es) | 2013-04-11 |
| RU2014118123A (ru) | 2015-11-20 |
| EP2774910A1 (en) | 2014-09-10 |
| ES2401629B1 (es) | 2014-03-04 |
| HUE035430T2 (en) | 2018-05-02 |
| EP3287437B1 (en) | 2019-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201605082RA (en) | Production Of Omega-Amino Fatty Acids | |
| PL2774910T3 (pl) | Enancjomery 2-hydroksy pochodnych kwasów tłuszczowych | |
| ZA201208372B (en) | Supplementation of fatty acids for improving alcohol productivity | |
| HK1201870A1 (en) | Enzymatic omega-oxidation and omega-amination of fatty acids | |
| ZA201308469B (en) | Nutritional compositions including branched chain fatty acids and methods of using same | |
| HK1210470A1 (en) | Hydropyrrolopyrrole derivatives for use as fatty acid synthase inhibitors | |
| HK1204604A1 (en) | Stereoselective total synthesis of noribogaine | |
| EP2761012A4 (en) | PREPARATION AND SECRETION OF FATTY ACIDS AND FATTY ACID DERIVATIVES | |
| EP2664328A4 (en) | COMPOUND PREPARATION FROM OMEGA-3 FATTY ACIDS | |
| HK1198515A1 (en) | Fatty acid compositions | |
| HK1205096A1 (en) | Method for the preparation of triglycerides of medium-chain length fatty acids | |
| EP2917358A4 (en) | COMPOSITIONS AND METHODS FOR THE BIOLOGICAL PRODUCTION OF FATTY ACID DERIVATIVES | |
| EP2827868A4 (en) | PHARMACEUTICAL COMPOSITIONS COMPRISING FATTY ACID ESTERS | |
| SI2906587T1 (sl) | Metode in sestave za izboljšano proizvodnjo maščobnih kislin in njihovih derivatov | |
| EP2809317A4 (en) | FATTY ACIDS AS ANTI-INFLAMMATORY AGENTS | |
| EP2744333A4 (en) | FETTSÄURESYNTHASEHEMMER | |
| EP2768966A4 (en) | BACTERIA AND PROCESS FOR THE SYNTHESIS OF FATTY ACIDS | |
| EP2726086A4 (en) | COMPOSITIONS CONTAINING FATTY NITROACIDS | |
| HUE038592T2 (hu) | Telítetlen zsírsavak és ezek származékai ózonizálása | |
| PT2636307E (pt) | Método de produção de composição antimicrobiana contendo ácidos gordos livres | |
| HK1200458A1 (en) | Methods of isolating 4-chloro-2-fluoro-3-substituted-phenylboronic acids 4--2--3-- | |
| HK1186172A1 (zh) | 製備 -氟- -羥基亞甲基－ -氧代丁酸酯的烯醇鹽方法 | |
| EP2782902A4 (en) | DERIVATIVES FROM PHENOXYISOBUTTERIC ACID | |
| AU2010903057A0 (en) | Acetylenation of fatty acids | |
| GB201104653D0 (en) | Improvements in the manufacture of fatty acids |